Home/Filings/4/0001127602-24-013947
4//SEC Filing

Davis Robert M 4

Accession 0001127602-24-013947

CIK 0000310158other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:14 PM ET

Size

6.0 KB

Accession

0001127602-24-013947

Insider Transaction Report

Form 4
Period: 2024-04-30
Davis Robert M
DirectorChairman, CEO & President
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-30+181,641181,641 total
    Exercise: $129.22From: 2025-04-30Exp: 2034-04-29Common Stock (181,641 underlying)
Holdings
  • Common Stock

    348,326.757
Footnotes (1)
  • [F1]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001363076

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:14 PM ET
Size
6.0 KB